Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Long-Term Investments (2016 - 2021)

Historic Long-Term Investments for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 11 years, with Q2 2021 value amounting to $44.8 million.

  • Lifecore Biomedical, Inc. \De\'s Long-Term Investments fell 2131.99% to $44.8 million in Q2 2021 from the same period last year, while for May 2021 it was $44.8 million, marking a year-over-year decrease of 2131.99%. This contributed to the annual value of $44.8 million for FY2021, which is 2131.99% down from last year.
  • Lifecore Biomedical, Inc. \De\'s Long-Term Investments amounted to $44.8 million in Q2 2021, which was down 2131.99% from $45.1 million recorded in Q1 2021.
  • Lifecore Biomedical, Inc. \De\'s 5-year Long-Term Investments high stood at $68.1 million for Q4 2018, and its period low was $44.8 million during Q2 2021.
  • Its 5-year average for Long-Term Investments is $60.3 million, with a median of $62.4 million in 2017.
  • Its Long-Term Investments has fluctuated over the past 5 years, first soared by 494.42% in 2017, then crashed by 2642.74% in 2020.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Long-Term Investments (Quarter) stood at $65.8 million in 2017, then rose by 3.5% to $68.1 million in 2018, then dropped by 9.99% to $61.3 million in 2019, then dropped by 26.43% to $45.1 million in 2020, then dropped by 0.73% to $44.8 million in 2021.
  • Its Long-Term Investments stands at $44.8 million for Q2 2021, versus $45.1 million for Q1 2021 and $45.1 million for Q4 2020.